NO955075L - Tienopyridoner - Google Patents

Tienopyridoner

Info

Publication number
NO955075L
NO955075L NO955075A NO955075A NO955075L NO 955075 L NO955075 L NO 955075L NO 955075 A NO955075 A NO 955075A NO 955075 A NO955075 A NO 955075A NO 955075 L NO955075 L NO 955075L
Authority
NO
Norway
Prior art keywords
hal
atoms
tienopyridoner
tienopyridone
nhac
Prior art date
Application number
NO955075A
Other languages
English (en)
Other versions
NO955075D0 (no
Inventor
Rudolf Gottschlich
Joachim Leibrock
Christian Noe
Michael Berger
Hans-Peter Buchstaller
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO955075D0 publication Critical patent/NO955075D0/no
Publication of NO955075L publication Critical patent/NO955075L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Tienopyridonderivater med formel I hvor B y i er CH eller N; er eller X R6 X NHAc; er H eller Hal; er -CH2-, -CO-, -O-, -NH-, -NÅ- eller S; er alkyl med 1-4 C-atomer; Ac er alkanoyl med 1-6 C-atomer eller benzoyl; og Hal er F, Cl, Br eller I; samt salter derav, utviser en høy affinitet til bindingssteder på amino- syrereseptorer og egner seg således til behandling av neurodegenerative sykdom- mer. Fremstillingen av forbindelsene er beskrevet.
NO955075A 1994-12-15 1995-12-14 Tienopyridoner NO955075L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4444815A DE4444815A1 (de) 1994-12-15 1994-12-15 Thienopyridone
CN95120906.XA CN1133843A (zh) 1994-12-15 1995-12-19 噻吩并吡啶酮

Publications (2)

Publication Number Publication Date
NO955075D0 NO955075D0 (no) 1995-12-14
NO955075L true NO955075L (no) 1996-06-17

Family

ID=37698014

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955075A NO955075L (no) 1994-12-15 1995-12-14 Tienopyridoner

Country Status (17)

Country Link
US (1) US5602144A (no)
EP (1) EP0717044A1 (no)
JP (1) JPH08239387A (no)
CN (1) CN1133843A (no)
AU (1) AU703603B2 (no)
BR (1) BR9505899A (no)
CA (1) CA2165129A1 (no)
CZ (1) CZ319395A3 (no)
DE (1) DE4444815A1 (no)
FI (1) FI956024A7 (no)
HU (1) HUT75091A (no)
NO (1) NO955075L (no)
PL (1) PL311838A1 (no)
RU (1) RU2155766C2 (no)
SK (1) SK157195A3 (no)
TR (1) TR199501562A2 (no)
ZA (1) ZA9510671B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE404568T1 (de) * 2001-03-14 2008-08-15 Gruenenthal Gmbh Substituierte thiazolopyrimidine als analgetika
GB0124848D0 (en) * 2001-10-16 2001-12-05 Celltech R&D Ltd Chemical compounds
US7119205B2 (en) * 2003-05-16 2006-10-10 Abbott Laboratories Thienopyridones as AMPK activators for the treatment of diabetes and obesity
SE0401578D0 (sv) * 2004-06-18 2004-06-18 Active Biotech Ab Novel compounds
EP1754483A1 (en) 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
UA103321C2 (ru) 2008-04-11 2013-10-10 Мерк Патент Гмбх Производные тиенопиридона как активаторы amp-активированной протеинкиназы (амрк)
SI2280952T1 (sl) * 2008-05-05 2012-09-28 Merck Patent Gmbh Derivati tienopiridona kot aktivatorji AMP-aktivirane protein kinaze (AMPK)
CA2735764C (en) * 2008-09-02 2016-06-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
EP2679591A1 (en) * 2012-06-29 2014-01-01 Poxel Thienopyridone derivatives useful as activators of AMPK

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026700A (en) * 1989-05-16 1991-06-25 Merrell Dow Pharmaceuticals Certain quinolines and thienopyridines as excitatory amino acid antagonists
NZ233641A (en) * 1989-05-16 1992-07-28 Merrell Dow Pharma Quinoline and thienopyridine derivatives and excitatory amino acid antagonistic pharmaceutical compositions
US5112821A (en) * 1989-05-16 1992-05-12 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists which are certain thienopyridives
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
US5129864A (en) * 1991-02-27 1992-07-14 Dayco Products, Inc. Tensioner for a power transmission belt and method of making the same
US5155115A (en) * 1991-03-12 1992-10-13 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
US5219864A (en) * 1991-03-12 1993-06-15 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
JPH05134373A (ja) * 1991-11-14 1993-05-28 Konica Corp 新規な写真用カプラー
DE4227747A1 (de) * 1992-08-21 1994-02-24 Basf Ag Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
NO955075D0 (no) 1995-12-14
FI956024L (fi) 1996-06-16
BR9505899A (pt) 1998-01-06
AU4029295A (en) 1996-06-20
RU2155766C2 (ru) 2000-09-10
CZ319395A3 (en) 1996-07-17
ZA9510671B (en) 1996-07-11
CN1133843A (zh) 1996-10-23
CA2165129A1 (en) 1996-06-16
SK157195A3 (en) 1996-07-03
FI956024A0 (fi) 1995-12-14
US5602144A (en) 1997-02-11
DE4444815A1 (de) 1996-06-20
PL311838A1 (en) 1996-06-24
TR199501562A2 (tr) 1996-07-21
HUT75091A (en) 1997-04-28
JPH08239387A (ja) 1996-09-17
FI956024A7 (fi) 1996-06-16
EP0717044A1 (de) 1996-06-19
AU703603B2 (en) 1999-03-25
HU9503582D0 (en) 1996-02-28

Similar Documents

Publication Publication Date Title
AU5169693A (en) Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
AU553419B2 (en) New deiphosphonic acid derivatives
GB9822376D0 (en) Stabilizer compounds
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
GR3030566T3 (en) Nipecotic acid derivatives as antithrombic compounds
IT1275997B1 (it) Enammine come accelleranti di vulcanizzazione per gomme naturali o sintetiche
AU641686B2 (en) Benzanilides
PL337188A1 (en) Derivatives of 17beta - allyloxy (thio) alkyl - androstane for modulation of meiosis
ZA89253B (en) Substituted 3-aminosydnonimines,process for the preparation thereof,and the use thereof
GR1002384B (el) Μεθοδος παρασκευης παραγωγων υποκατεστημενου στυρολιου.
NO940018D0 (no) Fremgangsmaate for fremstilling av svovelholdige imidazolderivater
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
AU3624189A (en) Phenothiazine derivatives, their preparation and pharmaceutical compositions containing them
ATE9347T1 (de) Salze von endo-8-methyl-8-syn-alkyl-8-
ES8504822A1 (es) Procedimiento para la preparacion de un nuevo derivado del pirrolo ortocondensado
AU2845489A (en) Process for preparing hydroxyakylating agents, the agents so obtained, and their use
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
ATE18993T1 (de) Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.
ATE102610T1 (de) Imidazolderivate, verfahren zu deren herstellung und diese enthaltende antiulkusmittel.
DE3477781D1 (en) Spiro(indolo(1,7-ab)(1,5)benzodiazepine-2,4'-piperidines) and intermediates, a process for the preparation thereof and their use as medicaments
GR81771B (no)
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ES2115303T3 (es) Uso de compuestos de 5-tia-1,4-diazabiciclo(4.2.0)octan-3,8-dioxo en terapia antitumoral.
HUP9701216A2 (hu) Új nitro-pirazol-észter-származékok, eljárás előállításukra és alkalmazásuk

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application